TELL ME MORE
ABOUT THIS CLINICAL TRIAL for an INFANT PNEUMOCOCCAL VACCINE
This is an Immunogenicity and Safety Study of an Expanded Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants Approximately 2 Months of Age
Infant Pneumococcal Vaccine
Study Location(s): Bowling Green Kentucky
This study evaluates the safety and immunogenicity of a 4-dose series of an expanded pneumococcal conjugatge vaccine in healthy infants and toddlers in comparison to current vaccines when both are administered together with routine pediatric vaccines. Click here for more information on Pneumococcal vaccines.
There is no cost to participate. Volunteers receive free vaccines and follow-up care. No insurance needed. Time and travel reimburrsement up to $400 may be available.
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ADHD A Long-term active comparitor and dose optimization study to evaluate safety and efficacy of a non-stimulat medication | Bowling Green Owensboro | Recruiting | 6 - 17 | $1150 | Request Info | |
| ADHD A randomized, double-blind, multicenter, placebo-controlled study to evaluatate efficacy and safety of an investigational medicine in preschool-age children | Bowling Green Evansville Owensboro | Coming Soon | 4 - 5 | $400 | Request Info | |
| ALOPECIA AREATA Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata | Owensboro | Recruiting | 18 - 65 | $500 | Request Info | |
| ASTHMA Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma | Evansville | Recruiting | 5 - 17 | $400 | Request Info | |
| COVID-19 Safety and Eficacy Study of a Monoclonal Antibody Therapy for Patients with Mild to Moderate COVID-19 | Evansville Owensboro | Recruiting | 18+ | $3000 | Request Info | |
| DIABETES (T2DM) Active Comparator Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors | BowlingGreen Owensboro | Recruiting | 40 + | $600/year (long-term study could last up to 5 years) | Request Info | |
| ECZEMA An open-label expanded access study in adult and adolescent patients age 12+ with moderate-to-severe Atopic Dermatitis (Eczema) | Evansville | Recruiting | 12+ | $60 per visit | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controlled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBS- CONSTIPATION An efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome | BowlingGreen Evansville | Recruiting | 6 - 17 | $350 | Request Info | |
| INFANT FORMULA 1. Fussy Baby Relief 2. Comparison Study | Evansville Owensboro | Enrolling | Newborns | 1. $150 + formula 2. $625 + formula | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| INFANT VACCINE Comparison Study between two pneumococcal vaccines | Bowling Green | Recruiting | Newborns | Variable up to $400 | Request Info | |
| LUPUS ERYTHEMATOSUS A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus | Evansville | Closed | 18 - 65 | $750 | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Recruiting | 6 - 17 | $200/$350 | Request Info | |
| PRURITUS (CHRONIC ITCH) An efficacy and safety study for the treatment of chronic itch in adult subjects with atopic dermatitis | Owensboro | Recruiting | 18 - 75 | $600 | Request Info | |
| RHEUMATOID ARTHRITIS (RA) This is a comparison study to evaluate an investigational medicine for Rheumatoid Arthritis in adults with moderately or severely active disease and who have had inadequate response to conventional synthetic or biologic Disease Modifying Anti-rheumatic Drugs (DMARDs). | Evansville | Closed | 18+ | Up to $1750 | Request Info | |